Status:
COMPLETED
Serum Tryptase Concentration During General Anaesthesia With Rocuronium
Lead Sponsor:
Medical University of Bialystok
Conditions:
Hypersensitivity Reaction
Eligibility:
FEMALE
18-80 years
Phase:
NA
Brief Summary
Rocuronium is a aminosteroid structured, non-depolarizing neuromuscular blocking agents (NMB). Epidemiological data presents that the frequency of hypersensitivity reactions caused by rocuronium have ...
Detailed Description
The greatest risk of hypersensitivity occurs during anesthesia for female patients and it is connected with the induction phase using skeletal muscle relaxants . Epidemiological data presents that the...
Eligibility Criteria
Inclusion
- ASA 1-2, no allergy and perioperative hypersensitivity reactions during anaesthesia
Exclusion
- steroid therapy, allergy in medical history, mastocytosis
Key Trial Info
Start Date :
June 25 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 15 2014
Estimated Enrollment :
126 Patients enrolled
Trial Details
Trial ID
NCT04035707
Start Date
June 25 2009
End Date
May 15 2014
Last Update
July 29 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.